ReadyCell scientists shared their expertise ane experience on the impact of pharmacologically relevant drug-drug interactions during drug discovery.
3rd SCI-RSC Symposium on Transporters in Drug Discovery and Development
Recent Posts
- Review of available cell-based in vitro models to evaluate intestinal permeability
- ReadyCell visits FarmaForum
- Drug Drug interaction studies in preclinical stage, reduces unexpected adverse events rate in clinical trails
- The evaluation of drug interactions in preclinical stages optimizes novel drug development
- Role of pharmacological efflux receptors in cancer treatment resistance
Tags
BCRP (3)
BLOOD-BRAIN BARRIER (2)
CACO2 (4)
CELL PRESERVATION (1)
CELL SHIPMENTS (1)
EFFLUX TRANSPORT (4)
EFFLUX TRANSPORTER (1)
EVENT (1)
HEK293 (3)
MATE 1 (4)
MDCK CELLS (4)
MDR1 (2)
OCT2 (3)
P-GP (3)
PERMEABILITY (5)
ROOM TEMPERATURE TRANSPORTATION (1)
SHIPPING (1)
TOXICITY (1)
UPTAKE TRANSPORT (4)